Patterns of visual field defect in CNS demyelinating diseases

被引：0

作者：

Kwak, J. G. ^{[1
]}

Park, M. S. ^{[2
,6
]}

Min, J. H. ^{[3
]}

Kwon, O. H. ^{[4
]}

An, J. Y. ^{[5
]}

Park, M. S. ^{[2
,6
]}

Kim, M. K. ^{[7
]}

Heo, K. G.

Kim, B. J. ^{[1
]}

Oh, S. Y. ^{[8
]}

Park, K. A. ^{[8
]}

Lee, K. H. ^{[1
]}

机构：

[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea

[2] Chonnam Natl Univ, Sch Med, Dept Neurol, Kwangju, South Korea

[3] Chung Ang Univ, Coll Med, Dept Neurol, Seoul 156756, South Korea

[4] Eulji Univ, Sch Med, Eulji Hosp, Dept Neurol, Seoul, South Korea

[5] Uijongbu Med Ctr, Dept Neurol, Uijongbu, South Korea

[6] Youngnam Univ, Coll Med, Dept Neurol, Taegu, South Korea

[7] Seoul Med Ctr, Dept Neurol, Seoul, South Korea

[8] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea

来源：

MULTIPLE SCLEROSIS | 2009年 / 15卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：139 / 139

页数：1

共 50 条

[31] Heterogeneity of the mechanisms of nerve cell damage in demyelinating autoimmune diseases of the CNS
Abdurasulova I.N.
Klimenko V.M.
Neuroscience and Behavioral Physiology, 2011, 41 (4) : 364 - 374
[32] Validation of a symptom-based questionnaire for pediatric CNS demyelinating diseases
Waldman, Amy T.
Yeshokumar, Anusha K.
Lavery, Amy
Liu, Geraldine
Pineles, Stacy L.
Repka, Michael X.
Adang, Laura
Narula, Sona
Liu, Grant T.
JOURNAL OF AAPOS, 2019, 23 (03): : 157 - 158
[33] Phosphorylated neurofilament heavy subunits as a marker of neurodegeneration in demyelinating diseases of the CNS
A. A. Vorobyeva
V. V. Fominykh
M. V. Onufriev
M. N. Zakharova
N. V. Gulyaeva
Neurochemical Journal, 2014, 8 : 221 - 225
[34] Non-infectious meningitis and CNS demyelinating diseases: A conceptual review
Etemadifar, M.
Fereidan-Esfahani, M.
Sedaghat, N.
Kargaran, P. K.
Mansouri, A. R.
Abhari, A. P.
Aghababaei, A.
Jannesari, A.
Salari, M.
Ganjalikhani-Hakemi, M.
Nouri, H.
REVUE NEUROLOGIQUE, 2023, 179 (06) : 533 - 547
[35] Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases
Di Pauli, Franziska
Mader, Simone
Rostasy, Kevin
Schanda, Kathrin
Bajer-Kornek, Barbara
Ehling, Rainer
Deisenhammer, Florian
Reindl, Markus
Berger, Thomas
CLINICAL IMMUNOLOGY, 2011, 138 (03) : 247 - 254
[36] Phosphorylated neurofilament heavy subunits as a marker of neurodegeneration in demyelinating diseases of the CNS
Vorobyeva, A. A.
Fominykh, V. V.
Onufriev, M. V.
Zakharova, M. N.
Gulyaeva, N. V.
NEUROCHEMICAL JOURNAL, 2014, 8 (03) : 221 - 225
[37] On how altered glutamate homeostasis may contribute to demyelinating diseases of the CNS
Matute, C
Domercq, M
Fogarty, DJ
de Zulueta, MP
Sánchez-Gómez, MV
THE FUNCTIONAL ROLES OF GLIAL CELLS IN HEALTH AND DISEASE: DIALOGUE BETWEEN GLIA AND NEURONS, 1999, 468 : 97 - 107
[38] SPATIOTEMPORAL RESPONSES OF THE VISUAL-SYSTEM IN DEMYELINATING DISEASES
MEDJBEUR, S
TULUNAYKEESEY, U
BRAIN, 1985, 108 (MAR) : 123 - 138
[39] VISUAL FIELD DEFECT IN GLAUCOMA
TAYLOR, TV
BRITISH MEDICAL JOURNAL, 1971, 4 (5784): : 429 - &
[40] Foggy visual field defect
Foroozan, R
Buono, LM
SURVEY OF OPHTHALMOLOGY, 2003, 48 (04) : 447 - 451

← 1 2 3 4 5 →